Literature DB >> 22190395

Molecular and cellular characterization of a Salmonella enterica serovar Paratyphi a outbreak strain and the human immune response to infection.

Ohad Gal-Mor1, Jotham Suez, Dana Elhadad, Steffen Porwollik, Eyal Leshem, Lea Valinsky, Michael McClelland, Eliezer Schwartz, Galia Rahav.   

Abstract

Enteric fever is an invasive life-threatening systemic disease caused by the Salmonella enterica human-adapted serovars Typhi and Paratyphi. Increasing incidence of infections with Salmonella enterica serovar Paratyphi A and the spreading of its antibiotic-resistant derivates pose a significant health concern in some areas of the world. Herein, we describe a molecular and phenotypic characterization of an S. Paratyphi A strain accounted for a recent paratyphoid outbreak in Nepal that affected at least 37 travelers. Pulsed-field gel electrophoresis analysis of the outbreak isolates revealed one genetic clone (pulsotype), confirming a single infecting source. Genetic profiling of the outbreak strain demonstrated the contribution of specific bacteriophages as a prime source of genetic diversity among clinical isolates of S. Paratyphi A. Phenotypic characterization in comparison with the S. Paratyphi A ATCC 9150 reference sequenced strain showed differences in flagellar morphology and increased abilities of the outbreak strain with respect to its motility, invasion into nonphagocytic cells, intracellular multiplication, survival within macrophages, and higher induction of interleukin-8 (IL-8) secreted by host cells. Collectively, these differences suggest an enhanced virulence potential of this strain and demonstrate an interesting phenotypic variation among S. Paratyphi A isolates. In vivo profiling of 16 inflammatory cytokines in patients infected with the outbreak strain revealed a common profile of a remarkable gamma interferon (IFN-γ) induction together with elevated concentrations of tumor necrosis factor alpha (TNF-α), IL-6, IL-8, IL-10, and IL-15, but not IL-12, which was previously demonstrated as elevated in nontyphoidal Salmonella infections. This apparent profile implies a distinct immune response to paratyphoid infections.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22190395      PMCID: PMC3272918          DOI: 10.1128/CVI.05468-11

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  49 in total

1.  ACT: the Artemis Comparison Tool.

Authors:  Tim J Carver; Kim M Rutherford; Matthew Berriman; Marie-Adele Rajandream; Barclay G Barrell; Julian Parkhill
Journal:  Bioinformatics       Date:  2005-06-23       Impact factor: 6.937

Review 2.  Evolution of host adaptation in Salmonella enterica.

Authors:  A J Bäumler; R M Tsolis; T A Ficht; L G Adams
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

3.  IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses.

Authors:  Z Xing; J Gauldie; G Cox; H Baumann; M Jordana; X F Lei; M K Achong
Journal:  J Clin Invest       Date:  1998-01-15       Impact factor: 14.808

Review 4.  Pathogenicity islands: bacterial evolution in quantum leaps.

Authors:  E A Groisman; H Ochman
Journal:  Cell       Date:  1996-11-29       Impact factor: 41.582

5.  Serum levels of interferon-gamma, interleukin-12, tumour necrosis factor-alpha, and interleukin-10, and bacterial clearance in patients with gastroenteric Salmonella infection.

Authors:  Marianna Stoycheva; Marianna Murdjeva
Journal:  Scand J Infect Dis       Date:  2005

6.  Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet.

Authors:  Efrain M Ribot; M A Fair; R Gautom; D N Cameron; S B Hunter; B Swaminathan; Timothy J Barrett
Journal:  Foodborne Pathog Dis       Date:  2006       Impact factor: 3.171

7.  Comparison of genome degradation in Paratyphi A and Typhi, human-restricted serovars of Salmonella enterica that cause typhoid.

Authors:  Michael McClelland; Kenneth E Sanderson; Sandra W Clifton; Phil Latreille; Steffen Porwollik; Aniko Sabo; Rekha Meyer; Tamberlyn Bieri; Phil Ozersky; Michael McLellan; C Richard Harkins; Chunyan Wang; Christine Nguyen; Amy Berghoff; Glendoria Elliott; Sara Kohlberg; Cindy Strong; Feiyu Du; Jason Carter; Colin Kremizki; Dan Layman; Shawn Leonard; Hui Sun; Lucinda Fulton; William Nash; Tracie Miner; Patrick Minx; Kim Delehaunty; Catrina Fronick; Vincent Magrini; Michael Nhan; Wesley Warren; Liliana Florea; John Spieth; Richard K Wilson
Journal:  Nat Genet       Date:  2004-11-07       Impact factor: 38.330

8.  Molecular genetic relationships of the salmonellae.

Authors:  E F Boyd; F S Wang; T S Whittam; R K Selander
Journal:  Appl Environ Microbiol       Date:  1996-03       Impact factor: 4.792

9.  The role of IL-12 in the maintenance of an established Th1 immune response in experimental leishmaniasis.

Authors:  C S Constantinescu; B D Hondowicz; M M Elloso; M Wysocka; G Trinchieri; P Scott
Journal:  Eur J Immunol       Date:  1998-07       Impact factor: 5.532

10.  Salmonella paratyphi A rates, Asia.

Authors:  R Leon Ochiai; XuanYi Wang; Lorenz von Seidlein; Jin Yang; Zulfiqar A Bhutta; Sujit K Bhattacharya; Magdarina Agtini; Jacqueline L Deen; John Wain; Deok Ryun Kim; Mohammad Ali; Camilo J Acosta; Luis Jodar; John D Clemens
Journal:  Emerg Infect Dis       Date:  2005-11       Impact factor: 6.883

View more
  20 in total

1.  Mix-infection of S. Typhi and ParaTyphi A in Typhoid Fever and Chronic Typhoid Carriers: A Nested PCR Based Study in North India.

Authors:  Chandra Bhan Pratap; Gopal Kumar; Saurabh Kumar Patel; Vijay K Shukla; Kailash Kumar; Tej Bali Singh; Gopal Nath
Journal:  J Clin Diagn Res       Date:  2014-11-20

2.  Profiling of Secreted Type 3 Secretion System Substrates by Salmonella enterica.

Authors:  Rivka Shem-Tov; Ohad Gal-Mor
Journal:  Methods Mol Biol       Date:  2022

3.  Feverlike Temperature is a Virulence Regulatory Cue Controlling the Motility and Host Cell Entry of Typhoidal Salmonella.

Authors:  Dana Elhadad; Michael McClelland; Galia Rahav; Ohad Gal-Mor
Journal:  J Infect Dis       Date:  2014-12-09       Impact factor: 5.226

Review 4.  Persistent Infection and Long-Term Carriage of Typhoidal and Nontyphoidal Salmonellae.

Authors:  Ohad Gal-Mor
Journal:  Clin Microbiol Rev       Date:  2018-11-28       Impact factor: 26.132

5.  Flagellin Is Required for Host Cell Invasion and Normal Salmonella Pathogenicity Island 1 Expression by Salmonella enterica Serovar Paratyphi A.

Authors:  Dana Elhadad; Prerak Desai; Galia Rahav; Michael McClelland; Ohad Gal-Mor
Journal:  Infect Immun       Date:  2015-06-08       Impact factor: 3.441

Review 6.  Paratyphoid fever: splicing the global analyses.

Authors:  Cindy Shuan Ju Teh; Kek Heng Chua; Kwai Lin Thong
Journal:  Int J Med Sci       Date:  2014-05-14       Impact factor: 3.738

7.  Multiple-locus variable number of tandem repeats analysis of Salmonella enterica serotype paratyphi A from Yuxi and comparison with isolates from the Chinese Medical Culture Collection Center.

Authors:  Yingbo Yao; Xiaoyan Cui; Qingshan Chen; Xinrong Huang; Bradley Elmore; Qing Pan; Shukun Wang; Jie Liu
Journal:  Mol Med Rep       Date:  2014-04-24       Impact factor: 2.952

Review 8.  Same species, different diseases: how and why typhoidal and non-typhoidal Salmonella enterica serovars differ.

Authors:  Ohad Gal-Mor; Erin C Boyle; Guntram A Grassl
Journal:  Front Microbiol       Date:  2014-08-04       Impact factor: 5.640

Review 9.  Salmonella-host interactions - modulation of the host innate immune system.

Authors:  Daniel Hurley; Matthew P McCusker; Séamus Fanning; Marta Martins
Journal:  Front Immunol       Date:  2014-10-07       Impact factor: 7.561

10.  Travel-associated illness trends and clusters, 2000-2010.

Authors:  Karin Leder; Joseph Torresi; John S Brownstein; Mary E Wilson; Jay S Keystone; Elizabeth Barnett; Eli Schwartz; Patricia Schlagenhauf; Annelies Wilder-Smith; Francesco Castelli; Frank von Sonnenburg; David O Freedman; Allen C Cheng
Journal:  Emerg Infect Dis       Date:  2013-07       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.